BACKGROUND: Studies suggest that prenatal vitamin D status may be inversely associated with lower respiratory tract infections (LRTIs) early in life. Studies of prenatal vitamin D status and development of asthma have inconsistent findings. METHODS: We examined the associations of maternal mid-pregnancy 25-hydroxyvitamin D [25(OH)D] level with the frequency of LRTIs by 36 months and with current asthma at 36 months using the Norwegian Mother and Child Cohort Study. Maternal plasma 25(OH)D level was measured using liquid chromatography-tandem mass spectrometry. Respiratory disorders were evaluated by maternal report through questionnaires. LRTIs were analysed in a random sample of 1248 children. Asthma was analysed using a case-control design, including 489 cases and 1183 controls. Multivariable generalised linear models calculated adjusted measures of association. RESULTS: The median gestational week of sample collection was 18 weeks (range 9, 35). The mean 25(OH)D level was 73.7 nmol/L (standard deviation 23.7). Higher maternal mid-pregnancy 25(OH)D level was associated with a reduced risk of three or more LRTIs by 36 months vs. none, adjusted risk ratio 0.74 [95% confidence interval (CI): 0.58, 0.93] per 20 nmol/L increase. Associations were similar when examining the frequency of LRTIs by 18 months, and the frequency of LRTIs between 18 and 36 months. Maternal mid-pregnancy 25(OH)D level was not significantly associated with current asthma at 36 months, adjusted odds ratio 0.91 [95% CI 0.81, 1.02] per 20 nmol/L increase. CONCLUSIONS: Higher maternal mid-pregnancy 25(OH)D level was associated with a modestly reduced risk of recurrent LRTIs by 36 months, but was not associated with current asthma at 36 months.
BACKGROUND: Studies suggest that prenatal vitamin D status may be inversely associated with lower respiratory tract infections (LRTIs) early in life. Studies of prenatal vitamin D status and development of asthma have inconsistent findings. METHODS: We examined the associations of maternal mid-pregnancy 25-hydroxyvitamin D [25(OH)D] level with the frequency of LRTIs by 36 months and with current asthma at 36 months using the Norwegian Mother and Child Cohort Study. Maternal plasma 25(OH)D level was measured using liquid chromatography-tandem mass spectrometry. Respiratory disorders were evaluated by maternal report through questionnaires. LRTIs were analysed in a random sample of 1248 children. Asthma was analysed using a case-control design, including 489 cases and 1183 controls. Multivariable generalised linear models calculated adjusted measures of association. RESULTS: The median gestational week of sample collection was 18 weeks (range 9, 35). The mean 25(OH)D level was 73.7 nmol/L (standard deviation 23.7). Higher maternal mid-pregnancy 25(OH)D level was associated with a reduced risk of three or more LRTIs by 36 months vs. none, adjusted risk ratio 0.74 [95% confidence interval (CI): 0.58, 0.93] per 20 nmol/L increase. Associations were similar when examining the frequency of LRTIs by 18 months, and the frequency of LRTIs between 18 and 36 months. Maternal mid-pregnancy 25(OH)D level was not significantly associated with current asthma at 36 months, adjusted odds ratio 0.91 [95% CI 0.81, 1.02] per 20 nmol/L increase. CONCLUSIONS: Higher maternal mid-pregnancy 25(OH)D level was associated with a modestly reduced risk of recurrent LRTIs by 36 months, but was not associated with current asthma at 36 months.
Authors: Kjersti S Rønningen; Liv Paltiel; Helle M Meltzer; Rannveig Nordhagen; Kari K Lie; Ragnhild Hovengen; Margaretha Haugen; Wenche Nystad; Per Magnus; Jane A Hoppin Journal: Eur J Epidemiol Date: 2006-09-20 Impact factor: 8.082
Authors: A ten Brinke; P J Sterk; A A M Masclee; P Spinhoven; J T Schmidt; A H Zwinderman; K F Rabe; E H Bel Journal: Eur Respir J Date: 2005-11 Impact factor: 16.671
Authors: Graham Devereux; Augusto A Litonjua; Stephen W Turner; Leone C A Craig; Geraldine McNeill; Sheelagh Martindale; Peter J Helms; Anthony Seaton; Scott T Weiss Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Carlos A Camargo; Sheryl L Rifas-Shiman; Augusto A Litonjua; Janet W Rich-Edwards; Scott T Weiss; Diane R Gold; Ken Kleinman; Matthew W Gillman Journal: Am J Clin Nutr Date: 2007-03 Impact factor: 7.045
Authors: Giuseppe Saggese; Francesco Vierucci; Flavia Prodam; Fabio Cardinale; Irene Cetin; Elena Chiappini; Gian Luigi De' Angelis; Maddalena Massari; Emanuele Miraglia Del Giudice; Michele Miraglia Del Giudice; Diego Peroni; Luigi Terracciano; Rino Agostiniani; Domenico Careddu; Daniele Giovanni Ghiglioni; Gianni Bona; Giuseppe Di Mauro; Giovanni Corsello Journal: Ital J Pediatr Date: 2018-05-08 Impact factor: 2.638
Authors: Anna Łuczyńska; Chad Logan; Alexandra Nieters; Magdeldin Elgizouli; Ben Schöttker; Hermann Brenner; Dietrich Rothenbacher Journal: Eur J Epidemiol Date: 2014-05-25 Impact factor: 8.082
Authors: Ramune Jacobsen; Steffen U Thorsen; Arieh S Cohen; Marika Lundqvist; Peder Frederiksen; Christian B Pipper; Flemming Pociot; Lau C Thygesen; Alberto Ascherio; Jannet Svensson; Berit L Heitmann Journal: Diabetologia Date: 2016-05-30 Impact factor: 10.122
Authors: David A Fried; Jane Rhyu; Karen Odato; Heather Blunt; Margaret R Karagas; Diane Gilbert-Diamond Journal: Nutr Rev Date: 2016-04-15 Impact factor: 7.110
Authors: Sarah N Adams; Margaret A Adgent; Tebeb Gebretsadik; Terryl J Hartman; Shanda Vereen; Christina Ortiz; Frances A Tylavsky; Kecia N Carroll Journal: J Matern Fetal Neonatal Med Date: 2019-05-02